Siligmueller & Norvid Wealth Advisors’s Merck MRK Stock Holding History

Siligmueller & Norvid Wealth Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$221K	Buy	+2,650	New	+$218K	0.1%	147

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Siligmueller & Norvid Wealth Advisors's MRK Position: Q3 2025 in Review

Siligmueller & Norvid Wealth Advisors opened a new position in Merck (MRK) in Q3 2025: 2,650 shares worth $221K. The stake represents 0.1% of the portfolio and ranks #147 among its holdings.

3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

Siligmueller & Norvid Wealth Advisors held 2,650 shares of Merck worth $221K as of Q3 2025.
Merck was a new Siligmueller & Norvid Wealth Advisors position in Q3 2025.
Merck made up 0.1% of Siligmueller & Norvid Wealth Advisors's portfolio in Q3 2025, its #147 holding.
3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Siligmueller & Norvid Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.